Tag: biopharmaceutical

MSD announces new regional president amid COVID-19 research

February 28, 2022

MSD, a trade name of US-based biopharmaceutical company Merck & Co., Inc., have revealed a new President for its Human Health Division in Asia Pacific: David Peacock, appointed from February 1, 2022. David brings a broad range of experience and perspectives to MSD from previous senior roles in the UK, US, and across Asia. “I […]

Continue Reading

Gyros Expands Asian Distribution to Singapore

June 11, 2012

SINGAPORE – Gyros’ nanoliter-scale immunoassay platform is now available to biopharmaceutical companies in Singapore. Gyrolab xP workstation  is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands. “We are very pleased to expand […]

Continue Reading